Sanofi
https://www.sanofi.com//
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sanofi
Stock Watch: Paradoxical Q1 Earnings Reactions
Falling sales are not typically welcomed by investors, while good revenue growth is prized. The first-quarter earnings season provided exceptions to this rule, and then there was Amgen.
Novavax Sanofi Pact Pacifies Unhappy Investor For Now
The US vaccines maker has been under the cosh from a very vocal investor who was unhappy with the performance of commercially disappointing COVID-19 shot Nuvaxovid and strategy in general. However, a recent pact with Sanofi worth up to $1.2bn has had a soothing effect.
'Future Fit' Cipla: Play In Oligonucleotides, Obesity Amid Promoter Stake Action
Cipla is stepping into the oligonucleotides space, where it also hopes to help shape the regulatory environment. Action is also anticipated in ‘big, identified areas’ such as obesity that may see potential partnering opportunities with Eli Lilly, with which the Indian firm has an existing alliance for diabetes therapies.
FTC Is Taking A Tougher Stance On Pharma, A Deputy Director Explains Why
Rahul Rao, the deputy director of the FTC Bureau of Competition, discussed the agency’s thinking on recent pharma deals that it viewed as anti-competitive.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
- Vaccines
- Other Names / Subsidiaries
-
- Ablynx N.V.
- Acambis PLC
- Avigen Inc.
- Bioverativ Inc. (True North Therapeutics, Inc.)
- BiPar Sciences Inc.
- BMP Sunstone Corporation
- Canderm Pharma Inc.
- Celmed BioSciences, Inc.
- Chattem, Inc.
- Connaught Laboratories Ltd.
- Fisons Ltd.
- Fovea Pharmaceuticals, SA
- Genfar S.A.
- Genzyme Corporation
- Groupe Sanofi
- Hoechst Marion Roussel
- Kadmon Holdings, Inc.
- Kiadis Pharma B.V.
- Kiadis Pharma N.V.
- Pluromed
- Principia Biopharma Inc. Protein Sciences Corporation
- Rhone-Poulenc Rorer
- Sanofi-Aventis
- Sanofi-aventis Groupe
- Sanofi Pasteur MSD
- Shantha
- Synthorx, Inc. (THOR)
- TargeGen, Inc.
- Thunder Acquisition
- Tidal Therapeutics
- Translate Bio
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice